Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation After Liver Transplantation

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
Sarcopenia is an independent predictor of morbidity and mortality in cirrhotic patient before and after liver transplantation. Beta-hydroxy-beta-methyl butyrate (HMB) is a leucine metabolite with potential efficacy in increasing protein synthesis, muscle mass and its functionality. The aim of this randomized controlled study is to evaluate the effect of a nutritional supplementation with HMB after liver transplantation both on muscle mass and on muscle function.
Epistemonikos ID: d2a5c9276983510be2ab0627016eb5c5fb892b95
First added on: May 21, 2024